CerTest Biotec and BD Announce COVID-19 Diagnostic Test
The molecular test for detection of COVID-19 is available to clinical laboratories in countries recognizing the CE mark.
Read MorePosted by | Mar 12, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The molecular test for detection of COVID-19 is available to clinical laboratories in countries recognizing the CE mark.
Read MorePosted by | Mar 12, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
PMLS’s COVID-19 test is undergoing FDA review for emergency use authorization to begin testing patient samples as soon as validation is completed.
Read MorePosted by | Mar 12, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The foundation will work in coordination with Public Health-Seattle and King County, the Washington State Department of Health, and the US Centers for Disease Control and Prevention to help enhance their capacity to detect and treat COVID-19.
Read MorePosted by Steve Halasey | Mar 12, 2020 | Compliance, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Lab Management |
CMS has issued a change request to inform Medicare administrative contractors about new HCPCS codes that are subject to and excluded from CLIA edits.
Read MorePosted by | Mar 11, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The International Atomic Energy Agency (IAEA) will provide diagnostic kits, equipment, and training in nuclear-derived detection techniques to countries asking for assistance in tackling the worldwide spread of the novel coronavirus causing COVID-19.
Read More